CTVA vs DVAX · P/E 42, rev $16.91B vs rev $277.2M
Corteva Inc (CTVA) versus Dynavax Technologies Corporation (DVAX) — a side-by-side from cached financials, not a winner call.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Dynavax Technologies Corporation (DVAX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Latest reported DVAX revenue for 2024-12-31 was $277.2M. Net income was $27.3M. Revenue was up 19.4% from 2023-12-31 to 2024-12-31. DVAX currently screens at market cap $1.82B.
CTVA currently screens at market cap $51.52B and trailing P/E 41.6. DVAX currently screens at market cap $1.82B.
Not investment advice. Open the CTVA and DVAX stock pages for the full models.
Not investment advice.